| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |